• Հայերեն
  • Русский
  • English
pharm.am
  • Home
  • About us
  • Main Functions
  • News and Announcements
  • Publications
  • Veterinary medicines
  • Contacts

Dear Healthcare Professional Letter

Tecentriq (atezolizumab)
Zometa (zoledronic acid) - risk of osteonecrosis of the jaw
L-Thyroxin Berlin-Chemie (levothyroxine) new formulation tablets: monitoring of patients switching between tablets
Therapy guide with Vsiqq (brolucizumab)
Actemra (tocilizumab)
Tecentriq (atezolizumab)
Direct Healthcare Professional Communication about Recormon (epoetin beta)
Novartis information on ophthalmic products based on Safety Notice provided by Becton Dickinson Company
Supply situation for Actemra IV - outlook for 2022
Kadcyla: Educational Information For Healthcare Professional

Page 1 of 6

  • 1
  • 2
  • 3
  • 4
  • ...
  • 6
  • Register
  • Guide to using "Database of registered medicines"
  • Drugs safety profile
  • ONLINE report about adverse effect of medicine

PUBLICATIONS

  • "Drugs and Medicines" Information Bulletin
  • “Safety of drugs” information leaflet
  • Dear Healthcare Professional Letter
  • Booklets
  • Dictionary

  • RSS
  • Facebook
  • Twitter
  • Home
  • About us
  • Main Functions
  • Committees and Councils
  • News and Announcements
  • Publications
  • Veterinary drugs
  • Contacts
  • SiteMap

Back to Top

© 2023 pharm.am